Maryland, 17 Feb 2023: The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals Inc's drug to treat an advanced eye disorder that is one of the leading causes of blindness globally, the company said on Friday.

 

The drug, which would be sold......
View Details

Related News

• Trial of Offences must be conducted by a Court of Sessions, there is no bar on a Magistrate taking cognizance of such offences: Jammu and Kashmir and Ladakh HC (14-03-2025)

---

• Dr Reddy’s recalls Levetiracetam Sodium Chloride Injection in US market (14-03-2025)

---

• Himachal: 1471 drugs samples failed quality tests in past two years: Minister in Assembly (14-03-2025)

---

• Licensing delays pushing medical device makers abroad: Parliament panel (14-03-2025)

---

• Four Smugglers Apprehended for Illicit Drug Sales; 2,930 Tablets Confiscated (14-03-2025)

---

• 2 antibiotic classes banned for use in animal rearing (13-03-2025)

---

• DoP organises workshop on PRIP Scheme (13-03-2025)

---

• Centre and States Prepare to Combat Narcotic Drug Abuse, May Require Barcodes on Packaging (13-03-2025)

---

• Large consignment of cough syrup recovered before Holi in Madhubani (13-03-2025)

---

• Poly Medicure gets MDR certification complying EU regulation for 54 products (13-03-2025)

---